Currently Viewing:
Kidney Week 2019
Time to Focus on Increasing Organs for Patients With ESRD, Azar Says at Kidney Week
November 07, 2019
Dr Tammy Brady Discusses the Role of the Pediatric Nephrologist on the Care Team for Metabolic Syndrome
November 07, 2019
Dr Danielle Kirkman Explains How Exercise Testing in Patients With CKD Can Improve Care
November 07, 2019
Dr Cynthia Delgado on the Importance of Patient Input in Kidney Disease Care
November 08, 2019
Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
November 08, 2019
Dr Joseph Vassalotti Presents Findings of AJMC® Study on CKD Intervention
November 08, 2019
Dr Alan Kliger Outlines Major Safety Risks for Patients Receiving Dialysis
November 08, 2019
Researchers Develop Tool to Identify Those at Risk of Future CKD
November 08, 2019
Paul Conway: Respect, Listening Are Keys to Engaging Patients in Kidney Care
November 08, 2019
Pooled Cardiovascular Data on Roxadustat Show No Increased Risk to Patients With CKD
November 08, 2019
Dr Jay Wish Explains Implications of New Roxadustat Data
November 09, 2019
Patients on Dialysis Have More Hospitalizations in Areas With More Black Residents
November 09, 2019
Physicians, Patient Discuss Intentional Nonadherence in Hypertension Therapy
November 10, 2019
Dr Holly Kramer Discusses Components of the Advancing American Kidney Health Initiative
November 11, 2019
Early Warning Signs of CKD Going Unnoticed in Veterans, Especially Those With Hypertension
November 11, 2019
As Kidney Week Ends, Providers Are Urged to Join New Care Models
November 11, 2019
Currently Reading
Understanding More About Quality of Life Impact for Patients With CKD, Anemia
November 11, 2019
Dr Danielle Kirkman Discusses the Biological Relationship Between Exercise and Hypertension
December 10, 2019
Dr Joseph Vassalotti on How Risk Stratification Informed a Primary Care CKD Intervention
December 11, 2019
Dr Tammy Brady on the Dangers of Missed, Incorrect Hypertension Diagnoses in Children
December 16, 2019
Dr Joseph Vassalotti Discusses Upstream Interventions Based on CKD Risk Stratification
December 20, 2019
Dr Danielle Kirkman on the Integration of Exercise Into the CKD Care Plan
December 23, 2019
Dr Tammy Brady Describes Efforts to Improve Diagnosis of Hypertension in Children
December 24, 2019
Dr Tammy Brady on Exciting Advances in Pediatric Nephrology
December 30, 2019

Understanding More About Quality of Life Impact for Patients With CKD, Anemia

Allison Inserro
A poster presented at the American Society of Nephrology's (ASN) Kidney Week 2019 sought to understand more about patient knowledge of anemia and its impact on patient quality of life, their understanding of the disease, as well as how their anemia is managed.
Of the 30 million patients in the United States with chronic kidney disease (CKD), about 5 million have anemia.  A poster presented at the American Society of Nephrology's (ASN) Kidney Week 2019 sought to understand more about patient knowledge of anemia and its impact on patient quality of life, their understanding of the disease, as well as how their anemia is managed.

A quantitative online survey was administered to 500 patients in the United States aged 18 and older between August and September 2018 with self-reported CKD, with or without anemia. They were recruited via online communities and support groups, patient associations, and patient referrals. Data were aggregated and anonymized to protect confidentiality.

Respondents were 69% female, with a mean age of 52.2 years; the majority (68%) said they had moderate to severe CKD (stages 3–5);  24% had CKD stage 1 or 2; the remainder did not know their stage.

Of the entire cohort (n = 255), 57% reported being told they had anemia by a healthcare professional. Of the total, 66% ( n= 168) knew about the relationship between anemia and CKD. Of the entire group, 38% (n = 170) knew their hemoglobin levels; most were aware of the key symptoms linked with anemia, such as fatigue or weakness.

As for reported symptoms, patients with anemia reported lack of energy (82%), feeling sad and/or depressed (53%), noting pain (52%), difficulty sleeping (53%), and worrying about worsening anemia (63%).

Most patients (67%) stated that their anemia was well-managed with iron supplements (55%) or erythropoiesis-stimulating agents (30%); 11% had received transfusions. Less than half felt confident that they knew the adverse effects of their treatment.

Half of the patients reported they knew about different treatment options for anemia, and they most frequently used online sources, including social media, to learn about anemia. However, patients most trusted information that came from their provider, they reported.

The patients perceived that anemia had a negative impact on their physical symptoms and emotional wellbeing, and their knowledge and understanding of CKD anemia and its management varied, the researchers reported. The researchers, funded by AstraZeneca, said the findings demonstrate the challenges providers and patients have concerning the need for further education on the association between CKD and anemia, symptoms associated with anemia, and the available treatment options for anemia.

Reference

Palaka E, Guzman NJ, Dunn A, Wittbrodt ET, Grandy S, Finkelstein FO. Understanding patient perspectives of the impact, awareness, and treatment of CKD anemia: A US patient survey. Presented at: American Society of Nephrology Kidney Week 2019, Washington, DC; November 5-10, 2019. Poster 232.

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up